The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jones Andrew D. since 2021.
This trader's CIK number is 1811872.
At the time of last reporting, Jones Andrew D. was the CFO of Novabay Pharmaceuticals, Inc.. (stock ticker symbol NBY).
Also see all insider trading activities at Novabay Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | NBY | 45,455 | $19,999 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-06 | NBY | Buy | 36,765 | .44 | 16,176 |
| 2021-12-03 | NBY | Buy | 8,690 | .44 | 3,823 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jones Andrew D. (CFO of Novabay Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.